Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China

Background: Maintenance therapy with the poly (ADP-ribose) polymerase inhibitors (PARPis) for platinum-sensitive recurrent ovarian carcinoma (OC) have proven to be effective compared with placebo. We aimed to evaluate the cost-effectiveness (CE) of maintenance fuzuloparib compared to routine surveil...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Jing, Wu, Huina, Sun, Lei, Ding, Yanjiao, Luan, Yepeng, Wu, Jiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846494/
https://www.ncbi.nlm.nih.gov/pubmed/36686677
http://dx.doi.org/10.3389/fphar.2022.987337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846494/
https://www.ncbi.nlm.nih.gov/pubmed/36686677
http://dx.doi.org/10.3389/fphar.2022.987337

Ejemplares similares